Morgan Stanley posted strong 1Q earnings on Friday, boosted by its equities trading business. Earnings also reflected the sale of loans tied to Elon Musk's purchase of X. The loans were on the ...

Morgan Stanley pulled in new assets at a healthy pace in the first three months of 2025. But company executives were reluctant to speculate about what current market turmoil will mean for the firm ...

Management's lack of specific forward guidance for Q2 and 2025 was concerning, however. Morgan Stanley is a major player in global financial services, offering a wide range of products and ...

Morgan Stanley's first-quarter profit rose as its traders cashed in on market volatility that boosted client activity. The bank today posted a profit of $4.3 billion, or $2.60 per share ...

Morgan Stanley on Friday reported first-quarter results that topped estimates as stock trading revenue surged 45% amid rising global volatility. The company said earnings rose 26% to $4.32 billion ...

Morgan Stanley said its profit jumped in the first quarter, fueled by a surge in trading revenue. The bank's profit increased 26% to $4.32 billion in the first three months of the year.

Both Mayo and Konrad have lowered their Q1 EPS estimates for Morgan Stanley, while Wells Fargo is also due to report on Friday. For Wells Fargo, Konrad boosted his estimate by one cent to $1.22 a ...

Morgan Stanley analyst Michael Ulz maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report) today and set a price target of $182.00. The company’s shares closed yesterday at ...

And that’s not even counting since “Liberation Day.” JPMorgan and Morgan Stanley both got huge boosts in their businesses helping clients trade equities in the first quarter, back when ...

Nvidia might be able to easily weather Trump's trade war, Morgan Stanley said. The bank said it believed the impact of tariffs on Nvidia's business could be "minimal." Demand for Nvidia's chips is ...

(Bloomberg) -- Morgan Stanley is no longer involved in providing financing for KKR & Co.’s purchase of Swedish consumer-health company Karo Healthcare, according to people familiar with the matter.